A systematic review of selection criteria for extirpative and combined surgical procedures in lower extremity lymphedema Authors: Star-Kayla Lewis, Samantha Cotes, Brooke Rothberg, Courtney Pina, Noah Sirkin, Jacqueline Morales, Adam Iddriss, Michael Cooper, Thomas O’Donnell, Alisha Oropallo Published: 2026 ABSTRACT AbstractBackgroundAdvanced lower extremity lymphedema is difficult to manage and can lead to significant functional impairment and diminished quality of life. Extirpative (also known as excisional and debulking) surgical procedures offer meaningful volume reduction for patients with advanced disease refractory to conservative management. The objective of this systematic review was to identify the clinical and imaging criteria used to determine candidacy for excisional surgery (ie, Charles and modified Homan procedures) in adults with lower extremity lymphedema and to report the surgical outcomes observed across the included studies.MethodsA systematic search of PubMed, Embase, and Cochrane Library was conducted by an expert medical librarian. The search yielded 3916 articles. Inclusion criteria involved randomized controlled trials, cohort studies, and case series that reported on excisional surgical procedures for adults with lower extremity lymphedema and described clinical or imaging criteria for surgical candidacy. Studies that did not involve patients with lower extremity lymphedema were excluded. Screening, full-text review, and data extraction were performed using Covidence software (Veritas Health Innovation) with standardized data extraction templates. This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.ResultsFive studies were included in this systematic review. There was a total of 933 patients across all studies. The five included studies were one systematic review, three retrospective cohorts or case series, and one small case series. Five clinical criteria for surgical candidacy were identified in this review: failure of conservative management, advanced clinical staging (International Society of Lymphology III or equivalent), functional impairment, skin changes, and recurrent infections. No imaging was used to determine surgical candidacy for excisional surgery alone in lower extremity lymphedema. Quality of life was not formally measured with validated instruments in any study.ConclusionsThis systematic review reveals a fundamental absence of validated, evidence-based selection criteria for extirpative surgery in lower extremity lymphedema. The current selection process is entirely surgeon dependent, institution specific, and nonstandardized. This represents a critical barrier to the development of clinical guidelines and equitable patient care. No existing evidence supports the superiority of any particular set of selection criteria over another.Keywords: Lymphedema, Lower extremity, Charles procedure, Modified Homan procedure, Patient selection Lower extremity lymphedema is a chronic and progressive condition characterized by the accumulation of protein-rich interstitial fluid resulting from impaired lymphatic drainage.1,2 The condition may arise as a primary disorder because of developmental abnormalities of the lymphatic system or as a secondary consequence of lymph node dissection, radiation therapy, infection, or trauma.3, 4, 5 Lower extremity lymphedema affects millions of individuals worldwide and is associated with significant morbidity, including chronic limb swelling, recurrent cellulitis, skin fibrosis, functional impairment, and diminished quality of life.6,7 The International Society of Lymphology (ISL) staging system classifies lymphedema into three stages based on clinical characteristics. Stage I represents early, reversible, pitting edema.7 Stage II represents irreversible, nonpitting edema with tissue fibrosis.8 Stage III represents lymphostatic elephantiasis with trophic skin changes.8 Conservative management includes decongestive therapy, manual lymphatic drainage, compression bandaging, and exercise.9,10 However, a substantial proportion of patients, particularly those with advanced-stage disease, experience inadequate responses to conservative therapy, prompting consideration of surgical intervention.11, 12, 13 Surgical approaches to lymphedema broadly fall into two categories. The first category includes physiologic procedures that aim to restore lymphatic drainage through lymphaticovenular anastomosis (LVA) or vascularized lymph node transfer (VLNT).14, 15, 16, 17, 18, 19, 20 The second category involves extirpative (excisional or debulking) procedures that directly remove lymphedematous tissue.21 Extirpative procedures include the Charles procedure, which involves radical excision with skin grafting; the modified Homan procedure, which includes staged subcutaneous excision beneath skin flaps; and suction-assisted lipectomy/liposuction.22 More recently, combined approaches integrating excisional and physiologic components have been described for end-stage disease.23 Despite the growing body of literature on surgical management of lymphedema, a critical gap persists regarding the criteria used to select patients for extirpative surgery. The determination of surgical candidacy, specifically clinical features and imaging findings, remains largely unstandardized. Individual surgeons and institutions apply varying combinations of clinical staging, conservative therapy failure, imaging confirmation, and functional assessment, with no consensus algorithm guiding patient selection.24,25 This heterogeneity has significant implications because inappropriate patient selection may lead to suboptimal outcomes, unnecessary surgical morbidity, or failure to offer surgery to patients who would benefit. Furthermore, the lower extremity has received less attention than the upper extremity in the surgical lymphedema literature.26 Many published studies and reviews focus predominantly or exclusively on upper extremity lymphedema following breast cancer treatment, and the applicability of their findings to lower extremity lymphedema populations is uncertain. The purpose of this systematic review is to identify the clinical and imaging criteria used to determine candidacy for excisional surgery (ie, Charles and modified Homan procedures) in adults with lower extremity lymphedema and to report the surgical outcomes described across the included studies. While an evaluation of the association between specific selection criteria and favorable outcomes was an aspirational aim of this review, the available literature was assessed for its capacity to support such an analysis. Methods Eligibility criteria Studies were eligible for inclusion if they met all the following criteria. The population of interest was adults aged 18 years or older with lower extremity lymphedema of any etiology, including primary or secondary. The intervention of interest was excisional surgical procedures, including the Charles procedure, modified Homan procedure, staged subcutaneous excision, or combined excisional and physiologic procedures (ie, excisional surgery combined with VLNT). The outcomes of interest included at least one of the following: clinical or imaging criteria used for surgical candidacy, volume or circumference reduction, functional outcomes, infection outcomes, compression garment use, quality of life, or complications. Any study design was eligible, including randomized controlled trials, prospective and retrospective cohort studies, case-control studies, case series, and systematic reviews. Given the limited literature on excisional surgery specifically for lower extremity lymphedema, broad inclusion of study designs was predetermined to maximize the capture of available evidence. Studies were excluded if they did not include patients who underwent procedures on the lower extremity; were published in languages other than English without available translation; were conference abstracts, editorials, commentaries, or expert opinion pieces without original data; or reported exclusively on physiologic procedures (ie, LVA or VLNT) without an excisional component. Information sources and search strategy A comprehensive search strategy was developed in collaboration with an expert medical librarian. The search was conducted initially in September 2025 and an updated search in April 2026. Three electronic databases were searched, including PubMed, Embase, and Cochrane Library. No filters or limits were applied. The search strategy combined controlled vocabulary terms, including MeSH and Emtree, along with free text keywords related to the following concepts: lymphedema, lower extremity, surgical treatment and excisional or debulking procedures, and patient selection or candidacy criteria. The full search strategies for all databases are present in Supplementary Appendix 1 (online only). Study selection All identified references were imported into Covidence systematic review software (Veritas Health Innovation) for management. The electronic search of PubMed, Embase, and Cochrane Library yielded a total of 3916 references. After the removal of duplicates, 2618 unique references remained for screening. Title and abstract screening resulted in the exclusion of 2556 references that did not meet the eligibility criteria. The majority of references excluded at this stage were removed for the following reasons: the study did not involve surgical treatment of lymphedema (n = 1284); the study focused exclusively on upper extremity lymphedema without a lower extremity component (n = 587); the study reported exclusively on physiologic procedures such as LVA or VLNT without an excisional component (n = 342); the study population did not include adults with lymphedema (n = 198); or the study was a conference abstract, editorial, commentary, or expert opinion without original data (n = 145). The remaining references at this stage were excluded for other reasons, including duplicate publications, non-English language without available translation, or irrelevance to the research question. Sixty-two full-text articles were assessed for eligibility, of which 57 were excluded. They were excluded for the following reasons: no excisional surgical procedure performed (n = 18), no lower extremity patients included or lower extremity data not separately reported (n = 15), no selection criteria for surgical candidacy described (n = 12), conference abstract or commentary without original data (n = 6), duplicate data from the same patient cohort (n = 4), and pediatric population exclusively (n = 2). Five studies met all inclusion criteria and were included in the final synthesis. The study selection process is presented in a Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram (Fig).27 Flow diagram illustrating the study selection process. A total of 3916 references were identified through Embase, PubMed, and Cochrane Library searches. After the removal of duplicates, 2618 unique references remained for screening. Title and abstract screening resulted in the exclusion of 2556 references that did not meet the eligibility criteria. Sixty-two full-text articles were assessed for eligibility, of which 57 were excluded. Five studies met all inclusion criteria and were included in the final synthesis. Data extraction Data extraction was performed using a standardized template in Covidence. For each included study, the following data were extracted: study characteristics, including author, year of publication, study design, study period, sample size, setting, and follow-up duration; population characteristics, including condition, etiology, age, sex distribution, disease duration, clinical stage, laterality, and exclusion criteria; clinical criteria for surgical candidacy, including but not limited to failure of conservative management, clinical staging system used, specific stage indicating surgical candidacy, functional impairment assessment, infection history, and tissue quality assessment; and imaging criteria for surgical candidacy, including the use of lymphoscintigraphy, indocyanine green lymphangiography, Doppler or duplex ultrasonography, computed tomography, magnetic resonance imaging, and specific imaging findings required for candidacy; comparator information, including the presence or the absence of a comparison group, nature of the comparator, and matching methodology; and outcomes, including volume or circumference reduction with time points, functional outcomes, infection outcomes, compression garment requirements, complications, quality-of-life measurements, and recurrence. Two reviewers independently extracted data, and discrepancies were resolved through discussion. Data synthesis Due to the anticipated heterogeneity in study designs, surgical procedures, selection criteria, outcome measures, and follow-up durations, a narrative synthesis approach was planned. The results were synthesized along two axes. The first was the identification and categorization of all clinical and imaging criteria used for surgical candidacy across studies. The second was the reporting and description of surgical outcomes observed across the included studies. A planned evaluation of the association between specific selection criteria and favorable outcomes was contingent on the availability of comparative data within the included studies. However, given the heterogeneity in study designs, surgical techniques, patient populations, and outcome measures, and the absence of any study directly comparing different sets of selection criteria, a formal associative analysis was not feasible. Results Study selection and characteristics The five included studies comprised one systematic review (Cormier et al), two retrospective cohort or case series (Mousavi and Sapountzis et al), one retrospective review of a prospectively collected database (Ciudad et al), and one small case series (Hassan and Chang). The studies were published between 2012 and 2021, with data collection periods spanning 1987 to 2019. Individual study sample sizes ranged from 3 to 816 patients. Follow-up periods ranged from 1 month to 25 years (Table I). Table ICharacteristics of included studiesStudyYearDesignnSettingFollow-upSurgical procedure(s)Population stageMousavi282016Retrospective cohort816Tehran, IranMinimum 1 yearModified Homan's (staged subcutaneous excision)Grade III-IV (equivalent)Ciudad et al232019Retrospective review of prospective database68Taiwan, PeruMean, 29 monthsCHAHOVA (Charles + Homan's + VLNT)ISL stage IIISapountzis et al292014Retrospective case series24TaiwanMean, 14 monthsModified Charles + VLNTISL stage III/Karri IIIb-IVHassan & Chang302020Case series3Chicago, USAVariableCharles procedureEnd stageCormier et al242012Systematic review22 (LE)InternationalVariableExcisionalAll stagesCHAHOVA, Combined Charles, Homan, and vascularized lymph node transfer; ISL, International Society of Lymphology; LE, lower extremity; VLNT, vascularized lymph node transfer.This table summarizes the five included studies by author, year of publication, study design, sample size, geographic setting, follow-up duration, surgical procedure performed, and population disease stage. The studies span from 2012 to 2020 and include sample sizes ranging from 3 to 816 patients across settings in Iran, Taiwan, Peru, the United States, and an international systematic review. Surgical procedures include the modified Homan technique, the CHAHOVA procedure combining excisional and physiologic approaches, the modified Charles procedure with VLNT, the Charles procedure alone, and multiple excisional procedure types within the systematic review. Disease stages ranged from grade III through IV equivalent in the Mousavi cohort to ISL stage III exclusively in the Ciudad et al and Sapountzis et al studies to end-stage disease in the Hassan and Chang case series. The systematic review by Cormier et al encompassed all stages across its included studies. The sample size reported for Cormier et al reflects only the LE patients among the excisional procedure studies within the systematic review. Follow-up durations ranged from variable in the Hassan and Chang case series and Cormier et al systematic review to a minimum of 1 year in the Mousavi study and means of 14 and 29 months in the Sapountzis et al and Ciudad et al studies, respectively. Characteristics of included studies CHAHOVA, Combined Charles, Homan, and vascularized lymph node transfer; ISL, International Society of Lymphology; LE, lower extremity; VLNT, vascularized lymph node transfer. This table summarizes the five included studies by author, year of publication, study design, sample size, geographic setting, follow-up duration, surgical procedure performed, and population disease stage. The studies span from 2012 to 2020 and include sample sizes ranging from 3 to 816 patients across settings in Iran, Taiwan, Peru, the United States, and an international systematic review. Surgical procedures include the modified Homan technique, the CHAHOVA procedure combining excisional and physiologic approaches, the modified Charles procedure with VLNT, the Charles procedure alone, and multiple excisional procedure types within the systematic review. Disease stages ranged from grade III through IV equivalent in the Mousavi cohort to ISL stage III exclusively in the Ciudad et al and Sapountzis et al studies to end-stage disease in the Hassan and Chang case series. The systematic review by Cormier et al encompassed all stages across its included studies. The sample size reported for Cormier et al reflects only the LE patients among the excisional procedure studies within the systematic review. Follow-up durations ranged from variable in the Hassan and Chang case series and Cormier et al systematic review to a minimum of 1 year in the Mousavi study and means of 14 and 29 months in the Sapountzis et al and Ciudad et al studies, respectively. Mousavi, in a study published in 2016, conducted a retrospective cohort study of 816 patients in Tehran, Iran, with a minimum 1-year follow-up. The surgical procedure was the modified Homan technique involving staged subcutaneous excision, and the population corresponded to grade III through IV disease based on the author's custom classification. Ciudad et al, in a study published in 2019, performed a retrospective review of a prospectively collected database including 68 patients from Taiwan and Peru with a mean follow-up of 29 months. Their procedure was the Combined Charles, Homan, and vascularized lymph node transfer technique, combining the Charles procedure, the Homan procedure, and VLNT, applied exclusively to patients with ISL stage III disease. Sapountzis et al, in a study published in 2014, performed a retrospective case series of 24 patients in Taiwan with a mean follow-up of 14 months. Their procedure combined the modified Charles procedure with VLNT for patients classified as ISL stage III or Karri stage IIIb through IV. Hassan and Chang, in a study published in 2020, reported a case series of three patients in the United States with variable follow-up. The surgical procedure was the Charles procedure performed on patients with end-stage disease. Cormier et al, in a study published in 2012, conducted a systematic review with 8 of 20 studies focused on excisional surgery. There was a total of 155 patients who received excisional surgery and 22 in the lower extremity. Population characteristics Across the five included studies, patients ranged in age from 20 to 86 years. Disease etiology was predominantly primary lymphedema in one study (Mousavi included 100% primary cases), whereas secondary or cancer-related lymphedema predominated in three studies (Ciudad et al, 66.2%; Sapountzis et al, 54.2%). Hassan and Chang included exclusively secondary lymphedema in all three patients, and the systematic review by Cormier et al reported mixed etiologies across included studies. Sex distribution varied considerably, with a male predominance in the Mousavi study at 60.8% male and female predominance in all other studies. Disease duration before surgery ranged from 1 year to 35 years. Clinical staging included ISL stage III and elephantiasis in most studies (Ciudad et al, Sapountzis et al, and Hassan and Chang) (Table II). Table IIPopulation characteristics of included studiesStudyAgeSex (% female)EtiologyDuration of diseaseISL stageLateralityMousavi2820-4539.2%100% primary1-35 yearsNot formally staged (grade III-IV equivalent)Bilateral 25%, unilateral 32.7%, and bilateral with unilateral surgery 42.2%Ciudad et al23Mean, 51 (22-64)75%Primary, 33.8%; secondary, 66.2%Mean, 72 month (48-108)Stage III exclusivelyUnilateralSapountzis et al29Mean, 53 y (37-78)75%Primary, 29.2%; secondary, 54.2%; and post-traumatic, 16.7%Mean, 7.2 yStage III/Karri IIIb-IVAll unilateralHassan & Chang3036-41 years33.3%100% secondary>13 years (case 1); longstanding (case 2); and not specified (case 3)End stageNot specifiedCormier et al24VariableVariablePredominantly secondaryVariableAll stagesVariableISL, International Society of Lymphology.This table presents the demographic and clinical characteristics of the patient populations across the five included studies. Patient ages ranged from 20 to 78 years across all studies. Etiology was exclusively primary in the Mousavi study, predominantly secondary in the Ciudad et al and Sapountzis et al studies, exclusively secondary in the Hassan and Chang study, and mixed across the Cormier et al systematic review. Sex distribution varied with a male predominance in the Mousavi cohort and female predominance in the Ciudad et al and Sapountzis et al studies. Disease duration before surgery ranged from 1 to greater than 13 years across individual studies. Clinical staging ranged from grade III through IV equivalent in the Mousavi cohort to ISL stage III exclusively in the Ciudad et al and Sapountzis et al cohorts to end-stage disease in the Hassan and Chang case series. The systematic review by Cormier et al encompassed all stages of disease across its included studies. Laterality was exclusively unilateral in the Sapountzis et al and Ciudad et al studies, whereas the Mousavi study included a mix of bilateral and unilateral involvement. Population characteristics of included studies ISL, International Society of Lymphology. This table presents the demographic and clinical characteristics of the patient populations across the five included studies. Patient ages ranged from 20 to 78 years across all studies. Etiology was exclusively primary in the Mousavi study, predominantly secondary in the Ciudad et al and Sapountzis et al studies, exclusively secondary in the Hassan and Chang study, and mixed across the Cormier et al systematic review. Sex distribution varied with a male predominance in the Mousavi cohort and female predominance in the Ciudad et al and Sapountzis et al studies. Disease duration before surgery ranged from 1 to greater than 13 years across individual studies. Clinical staging ranged from grade III through IV equivalent in the Mousavi cohort to ISL stage III exclusively in the Ciudad et al and Sapountzis et al cohorts to end-stage disease in the Hassan and Chang case series. The systematic review by Cormier et al encompassed all stages of disease across its included studies. Laterality was exclusively unilateral in the Sapountzis et al and Ciudad et al studies, whereas the Mousavi study included a mix of bilateral and unilateral involvement. Clinical criteria for surgical candidacy Failure of conservative management Failure of conservative management was the most consistently applied clinical criterion across all five studies. However, the definition, duration, and documentation of conservative therapy failure varied substantially. Mousavi required a minimum of 6 months of failed elastic compression stocking therapy at class III with persistent predominant swelling and disability before surgical consideration. Ciudad et al required failed complete decongestive therapy, defining failure as the inability to achieve goals of size reduction and infection elimination without specifying a minimum duration. Sapountzis et al indicated surgery when conservative methods, including limb elevation and compression elastic bandages, had failed without specifying duration. Hassan and Chang described all three patients as refractory to conservative management, with one patient's limb being too large for any wrapping or lymphedema therapy. The systematic review by Cormier et al identified failed conservative treatment as a universal prerequisite across the 20 studies reviewed, stating that surgery for lymphedema has been advocated when adequate trials of standard treatment regimens have failed. Clinical staging Clinical staging was used as a selection criterion in all five studies, though the staging systems and threshold stages varied. Three studies explicitly required ISL stage III disease for combined excisional and physiologic procedures (Ciudad et al and Sapountzis et al), or equivalent end-stage disease (Hassan and Chang). Mousavi did not use the ISL system but described a four-grade clinical classification with the study population corresponding to grade III through IV based on the description of chronic nonpitting edema. The systematic review by Cormier et al noted that severity determines procedure type, with excisional procedures recommended for severe lymphedema. Regarding the specific stage descriptions used across studies, Mousavi described grade III as severe nonpitting edema without skin reaction and grade IV as skin reaction or elephantiasis. Ciudad et al described stage III as fibrosclerotic tissue with papillomatous and verrucous skin hypertrophy and trophic toe changes. Sapountzis et al described stage III and Karri stage IIIb through IV as irreversible skin fibrosis with leather-like skin, ulcers, and potential toe involvement. Hassan and Chang did not formally apply a staging system but described end-stage disease characterized by fibrotic tissue and massive limb enlargement with inability to apply compression. Cormier et al noted that no universally applied grading system was identified across their included studies. Functional impairment Functional limitation was explicitly required as a selection criterion in three studies. Ciudad et al specified limitation of mobility and activities of daily living as one of four mandatory clinical criteria. Hassan and Chang described severe functional impairment, including inability to ambulate, work, or wear normal clothing and shoes in all three cases. Mousavi referenced persistent predominant swelling and disability as the threshold for surgical consideration. The remaining studies did not explicitly require documented functional impairment as a candidacy criterion. Skin changes and tissue quality Specific skin changes and tissue quality were required as a selection criterion in four studies. Ciudad et al required the presence of discoloration, cobblestoning, or ulceration as one of four mandatory criteria. Sapountzis et al described irreversible skin fibrosis, hyperkeratosis, leather-like skin, and skin crypts as features characterizing their study population. Hassan and Chang noted fibrotic tissue quality as the determining factor that precluded candidacy for liposuction or physiologic microsurgery, thus directing patients toward the Charles procedure. The systematic review identified tissue composition as a key factor in determining procedure type, distinguishing between fibrotic and fibrosclerotic tissue requiring excisional procedures and adipose-predominant tissue suitable for liposuction. Recurrent infections Recurrent infections were explicitly required as a selection criterion in two studies. Ciudad et al required recurrent episodes of infection as one of four mandatory criteria, with a preoperative mean of 4.2 ± 3.2 episodes of cellulitis per person per year. Sapountzis et al required a history of at least one episode of infection. Hassan and Chang noted recurrent cellulitis in at least one of three cases. The remaining studies did not explicitly require infection history as a candidacy criterion. Imaging criteria for surgical candidacy Imaging criteria for surgical candidacy were only used in studies that received a combined physiologic procedure with excisional surgery. Therefore, for excisional surgery, selection is entirely based on clinical assessment. Reported surgical outcomes following extirpative procedures While the primary aim of this review was to identify and synthesize the selection criteria employed for extirpative surgery in lower extremity lymphedema, the reported surgical outcomes across included studies provide important context for evaluating these procedures. Table III summarizes the outcomes following extirpative surgery. Table IIISummary of reported surgical outcomes following extirpative proceduresOutcomeMousaviCiudad et alSapountzis et alHassan and ChangCormier et alN8166824322 (LE)Follow-upMinimum 1 yearMean, 29 monthsMean, 14 monthsVariableVariableVolume/ circumference reduction36%-46%67.4%-98.1%100% normalization25-50+ kg excised91.1% (mixed UE/LE)Return to function87.8%100%100%100%VariableCompression discontinuationNot reported100% at 6 months3-4 months then DCNot reportedUniversal requirementCellulitis reductionNot reported4.2 to 1.2 episodes/y1/24 (4.2%) postopNot reportedNot reportedMajor complicationsNoneNoneNoneYes (case 2: 3L EBL, ICU stay)VariableMinor complications5.4% seroma, 3% wound infection, and 2.3% flap ischemia13.2% (graft loss, scarring, delayed healing, and infection)8.3% graft loss requiring regrafting, 25% partial graft lossCase 3: wound infection, <10% graft sloughVariableReoperation rateNot reported7.4%8.3%Not reportedNot reportedRecurrence4% fair/poor outcomesNo recurrenceNo recurrenceNot reportedNot reportedQoL (validated instrument)NoNoNoNoNoDC, Discontinue; EBL, estimated blood loss; ICU, intensive care unit; LE, lower extremity; QoL, quality of life; UE, upper extremity.This table summarizes the reported surgical outcomes across the five included studies, presented separately from the selection criteria to reflect that outcomes are retrospective observations dependent on multiple factors and are not available at the time of surgical decision-making. Volume reduction outcomes varied substantially, reflecting differences in surgical procedures, disease severity, and measurement methods. Functional outcomes were favorable across all studies, though no study employed standardized or validated functional outcome measures. Complication rates varied, with the majority of complications being minor and managed conservatively. QoL was not formally measured using a validated instrument in any study, representing a critical gap in the evidence base. The concurrent differences in surgical techniques, patient populations, and perioperative protocols preclude attributing outcomes solely to the selection criteria used. Summary of reported surgical outcomes following extirpative procedures DC, Discontinue; EBL, estimated blood loss; ICU, intensive care unit; LE, lower extremity; QoL, quality of life; UE, upper extremity. This table summarizes the reported surgical outcomes across the five included studies, presented separately from the selection criteria to reflect that outcomes are retrospective observations dependent on multiple factors and are not available at the time of surgical decision-making. Volume reduction outcomes varied substantially, reflecting differences in surgical procedures, disease severity, and measurement methods. Functional outcomes were favorable across all studies, though no study employed standardized or validated functional outcome measures. Complication rates varied, with the majority of complications being minor and managed conservatively. QoL was not formally measured using a validated instrument in any study, representing a critical gap in the evidence base. The concurrent differences in surgical techniques, patient populations, and perioperative protocols preclude attributing outcomes solely to the selection criteria used. Volume and circumference reduction Volume reduction outcomes varied substantially across studies, reflecting differences in surgical procedures, disease severity, selection criteria, and measurement methods. The highest circumference reduction rates were reported by studies selecting for advanced-stage disease and employing radical excisional procedures with physiologic components. Mousavi reported circumference reductions using the modified Homan procedure in patients selected based on failed compression. At 1-year follow-up, supramalleolar circumference reduction was 36%, midcalf reduction was 46%, and midthigh reduction was 40%. Ciudad et al reported circumference reduction rates using the Combined Charles, Homan, and vascularized lymph node transfer procedure. These patients were selected based on ISL stage III classification, failed decongestive therapy, skin changes, and recurrent infection. The upper thigh circumference reduction rate was 67.4%, and the rest of the limb achieved a 98.1% reduction at a mean follow-up of 29 months. Sapountzis et al reported 100% circumference normalization, meaning equalization to the contralateral limb. This study used the modified Charles procedure with VLNT. These patients were selected based on ISL stage III classification and failed conservative therapy. Hassan and Chang reported tissue excision of 25 to more than 50 kg using the Charles procedure in patients. They were selected based on end-stage disease and failure of all therapies. No systematic circumferential or volumetric measurements were performed in this study. Last, the systematic review by Cormier et al reported weighted average volume reductions across procedure categories, with excisional procedures achieving 91.1% reduction ranging from 18% to 118%. However, these are mixed upper and lower extremity data. These findings suggest that more comprehensive clinical selection criteria may be associated with greater volume reduction. However, the concurrent differences in surgical techniques preclude definitive conclusions about the independent contribution of selection criteria. Functional outcomes Functional outcomes were favorable across all studies, though measurement methods were unstandardized. Mousavi reported that 716 of 816 patients (87.8%) achieved excellent outcomes, defined as symptom free with no disability, and an additional 63 patients (7.7%) achieved acceptable outcomes, defined as socially active with residual edema. Ciudad et al reported that all 68 patients returned to normal daily activities, and all were able to discontinue compression garments at a mean of 6 months. Sapountzis et al reported that all 24 patients returned to daily activities within 2 months postoperatively. Hassan and Chang reported that all three patients ultimately recovered to exceed their preoperative activity levels with satisfactory outcomes. Notably, Ciudad et al reported that all 68 patients were able to discontinue compression garments postoperatively with no recurrence of lymphedema. This finding was attributed to the combined excisional and physiologic approach and the restored regional immune function provided by VLNT. This contrasts with the systematic review finding that postoperative compression was nearly universally required across all other studies. Infection outcomes Infection-related outcomes improved substantially. Ciudad et al reported a decrease from a preoperative mean of 4.2 ± 3.2 episodes of cellulitis per person per year to a postoperative mean of 1.2 ± 0.8 episodes, with only 2 of 68 patients (2.9%) experiencing any single episode during follow-up. Sapountzis et al reported that only 1 of 24 patients (4.2%) developed cellulitis at 13 months postoperatively, compared with a preoperative history of at least one episode in all patients. Complications Complication rates varied across studies. Mousavi reported no major complications, with minor complications including seroma in 44 patients (5.4%) managed with repeated aspirations, wound infection in 24 patients (3%), and flap ischemia in 19 patients (2.3%) managed conservatively. Ciudad et al reported zero major complications and nine minor complications (13.2%), including partial skin graft loss in one patient, hypertrophic scarring in four patients, delayed wound healing in two patients, and infection in two patients. Five patients (7.4%) required reoperation. Sapountzis et al reported no major complications, with minor complications including partial skin graft loss requiring regrafting in two patients (8.3%), partial skin graft loss in six patients (25%), and partial skin flap loss in one patient (4.2%). Hassan and Chang reported significant perioperative morbidity in case 2, including an estimated blood loss of 3000 mL requiring 14 units of packed red blood cells and 13 units of fresh frozen plasma, a 7-day intensive care unit stay, and a 23-day hospital admission. Case 3 experienced wound infection with less than 10% skin graft slough requiring operative debridement. Quality of life No study measured quality of life using a validated patient-reported outcome instrument. Quality of life was indirectly assessed through functional status descriptions in all studies (see the Functional outcomes section for details). Recurrence Recurrence was explicitly reported in three studies. Sapountzis et al reported no recurrence during a mean 14-month follow-up. Ciudad et al reported no recurrence after compression garment discontinuation. Mousavi did not systematically report recurrence but noted 4% fair or poor outcomes. Discussion Principal findings This systematic review identified and synthesized the clinical and imaging criteria used to determine candidacy for extirpative surgery in adults with lower extremity lymphedema across five studies. Table IV demonstrates a comprehensive summary of selection criteria and associated outcomes. Five clinical criteria for surgical candidacy were identified: failure of conservative management, advanced clinical staging (ISL stage III or equivalent), functional impairment, skin changes, and recurrent infections. Failure of conservative management was a clinical criterion universally applied across all included studies. However, the definition of failure and the minimum duration required before surgical consideration varied substantially. This heterogeneity limits the ability to define a standardized threshold for conservative therapy failure that should trigger surgical referrals. Table IVComprehensive summary of selection criteria and associated outcomesCriterionMousaviCiudad et alSapountzis et alHassan and ChangCormier et alStudy and patient characteristics Number of patients8166824322 (LE) Age (years)20-45Mean, 51 (22-64)Mean, 53 (37-78)36-41Variable Sex (% female)39.2%75%75%33.3%Variable Etiology100% primaryPrimary, 33.8%; secondary, 66.2%Primary, 29.2%; secondary, 54.2%; and post-traumatic, 16.7%100% secondaryPredominantly secondary Disease duration1-35 yearsMean, 72 months (48-108)Mean, 7.2 years>13 years (case 1); longstanding (case 2); and NR (case 3)Variable LateralityBilateral, 25%; unilateral, 32.7%; and bilateral with unilateral surgery, 42.2%UnilateralAll unilateralNRVariable Surgical procedureModified Homan (staged subcutaneous excision)CHAHOVA (Charles + Homan + VLNT)Modified Charles + VLNTCharles procedureExcisional (various) Length of follow-upMinimum 1 yearMean, 29 monthsMean, 14 monthsVariableVariableClinical selection criteria Failed conservative therapyYes (>6 months)YesYesYesYes Clinical staging systemCustom 4-gradeISLISL and KarriNonformalVariable Stage thresholdGrade III-IVStage IIIStage III and IIIb-IVEnd stageVariable Functional limitation requiredYes (disability)Yes (mandatory)NoYes (clinical)No Skin changes requiredNoYes (mandatory)Yes (present)Yes (present)No Recurrent infection requiredNoYes (mandatory)Yes (>1 episodes)Yes (present)No Tissue quality assessedNoYes (fibrosclerotic)Yes (fibrotic)Yes (fibrotic)YesImaging selection criteria LymphoscintigraphyNoNoYes (mandatory)NoReferenced ICG lymphangiographyNoNoNoNoNo Doppler ultrasonographyYesNoNoNoNo CT or MRINoNoNoNoNo No imaging describedNoYesNoYesNoCHAHOVA, Combined Charles, Homan, and vascularized lymph node transfer; CT, computed tomography; ICG, indocyanine green; ISL, International Society of Lymphology; LE, lower extremity; MRI, magnetic resonance imaging; NR, not reported; VLNT, vascularized lymph node transfer.This table presents a comprehensive side-by-side comparison of all clinical and imaging selection criteria applied across the five included studies, alongside study-level and patient-level characteristics. The study and patient characteristics section includes the number of patients, age range, sex distribution, disease etiology, disease duration before surgery, laterality, surgical procedure performed, and length of follow-up for each included study. These characteristics were included to enable the reader to contextualize the selection criteria within the clinical profile of each study population. All five studies required failure of conservative therapy as a prerequisite for surgical candidacy. Clinical staging was applied in all five studies using varying classification systems and stage thresholds. Supporting clinical criteria, including functional limitation, skin changes, recurrent infection, and tissue quality assessment, were applied variably across studies. Imaging criteria were used in two of five individual studies, with lymphoscintigraphy mandatory in one study and Doppler ultrasonography mandatory in another. Two studies reported no imaging criteria of any kind. Sample sizes ranged from 3 to 816 patients, and follow-up durations ranged from variable to a mean of 29 months, reflecting substantial heterogeneity across studies. Disease etiology was exclusively primary in one study, predominantly secondary in three studies, and mixed in the systematic review. Comprehensive summary of selection criteria and associated outcomes CHAHOVA, Combined Charles, Homan, and vascularized lymph node transfer; CT, computed tomography; ICG, indocyanine green; ISL, International Society of Lymphology; LE, lower extremity; MRI, magnetic resonance imaging; NR, not reported; VLNT, vascularized lymph node transfer. This table presents a comprehensive side-by-side comparison of all clinical and imaging selection criteria applied across the five included studies, alongside study-level and patient-level characteristics. The study and patient characteristics section includes the number of patients, age range, sex distribution, disease etiology, disease duration before surgery, laterality, surgical procedure performed, and length of follow-up for each included study. These characteristics were included to enable the reader to contextualize the selection criteria within the clinical profile of each study population. All five studies required failure of conservative therapy as a prerequisite for surgical candidacy. Clinical staging was applied in all five studies using varying classification systems and stage thresholds. Supporting clinical criteria, including functional limitation, skin changes, recurrent infection, and tissue quality assessment, were applied variably across studies. Imaging criteria were used in two of five individual studies, with lymphoscintigraphy mandatory in one study and Doppler ultrasonography mandatory in another. Two studies reported no imaging criteria of any kind. Sample sizes ranged from 3 to 816 patients, and follow-up durations ranged from variable to a mean of 29 months, reflecting substantial heterogeneity across studies. Disease etiology was exclusively primary in one study, predominantly secondary in three studies, and mixed in the systematic review. Imaging criteria were only used for combined excisional and physiologic procedures. Lymphoscintigraphy was used for vascular lymph node transfer in one study and not for the excisional procedure. No study employed a validated multicomponent selection algorithm, and the systematic review by Cormier et al explicitly identified the lack of patient selection criteria as a deficiency across the literature. This absence represents the most significant finding of this review in that the current state of the field is characterized by surgeon-dependent, institution-specific, and nonstandardized selection processes. Last, the reported surgical outcomes, summarized in Table III, demonstrate that extirpative procedures can achieve meaningful volume reduction, functional improvement, decreased cellulitis frequency, and acceptable complication profiles in appropriately selected patients. However, it is important to recognize that these outcomes are retrospective observations dependent on multiple factors and cannot serve as prospective selection criteria. The concurrent differences in surgical techniques, patient populations, and perioperative management protocols across studies preclude attributing outcomes solely to the selection criteria used. Interpretation and contextualization The universal requirement for conservative therapy failure before surgical consideration is consistent with established treatment algorithms for lymphedema, which position surgery as a second-line intervention. However, the definition of failure remains problematic. Mousavi required a specific minimum duration of 6 months of compression therapy, whereas other studies used subjective clinical judgment. The optimal duration and intensity of conservative therapy before surgical referral remains undefined. Prolonged delays in surgical referral may allow disease progression to stages where physiologic procedures are no longer effective, necessitating more extensive excisional surgery. Conversely, premature surgical intervention in patients who might respond to optimized conservative management may expose them to unnecessary operative risk. Comparison with previous reviews The systematic review by Cormier et al, which examined the literature from 2004 to 2010, identified similar themes, including a lack of standardized selection criteria, heterogeneous outcome measures, the absence of quality-of-life assessments, and the near-universal requirement for postoperative compression. The present review, incorporating studies published through 2021, demonstrates that while surgical techniques have evolved substantially, particularly with the advent of combined excisional and physiologic procedures, the fundamental gap in standardized selection criteria persists. Limitations Several limitations must be acknowledged. The included studies were heterogeneous in design, surgical procedures, patient populations, selection criteria, outcome measures, and follow-up durations. This precluded meta-analysis or statistical comparison of selection criteria. No study measured quality of life with a validated instrument, leaving a critical patient-centered outcome unaddressed. The small number of 5 included studies reflects the limited literature on this topic rather than overly restrictive inclusion criteria. Finally, three of the five included studies involved physiologic procedures alongside excisional surgery. These were included because they provided relevant data on selection criteria applicable to the research question and because combined excisional and physiologic procedures are increasingly recognized as the standard of care for advanced lower extremity lymphedema. Implications for clinical practice Based on the available evidence, clinicians considering patients for extirpative surgery for lower extremity lymphedema should document an adequate trial of conservative management, including complete decongestive therapy and compression therapy, with either failure or plateau, ideally for a minimum of 6 months. Clinicians should classify disease severity using a recognized staging system such as the ISL classification and match the surgical approach to disease stage. Last, clinicians should assess and document functional impairment, skin changes, and infection history. Structured perioperative management protocols should be implemented, as these may significantly influence outcomes independent of patient selection. Implications for research The findings of this review highlight several critical research needs. Prospective validation of selection criteria is needed to compare outcomes in patients selected using standardized criteria. Future studies should perform subgroup analyses comparing outcomes based on clinical stage, duration of symptoms, tissue quality, and other potential prognostic factors to identify which specific criteria are most predictive of favorable outcomes. All future studies should incorporate validated patient-reported outcome measures, such as the lymphedema quality-of-life questionnaire, as primary outcomes. Consensus on standardized volume measurement techniques and outcome reporting would enable meaningful cross-study comparisons. Conclusions This systematic review reveals a fundamental absence of validated selection criteria for extirpative surgery in lower extremity lymphedema. Five clinical criteria were identified as the most consistently applied: failure of conservative management, advanced clinical staging, functional impairment, skin changes, and recurrent infections. However, no two studies employed identical selection processes, and no study provided evidence-based justification for its chosen criteria or validated them against surgical outcomes. Imaging criteria were absent for excisional surgery alone. Quality of life was not measured using a validated instrument in any study. The current selection process is entirely surgeon dependent, institution specific, and nonstandardized, representing a critical barrier to the development of clinical guidelines. There is an urgent need for the development and prospective validation of a consensus-based multicomponent selection algorithm with standardized outcome reporting and validated patient-reported outcome measures. Ethics approval Not applicable (systematic review of published literature). Data availability A protocol for this review was prepared and available via PROSPERO. Author Contributions Conception and design: SKL, TO, AO Analysis and interpretation: SKL, CP, JM, MC, AO Data collection: SKL, SC, BR, CP, NS, JM, AI Writing the article: SKL, SC, BR, CP, NS, JM, AI Critical revision of the article: SKL, MC, TO, AO Final approval of the article: SKL, SC, BR, CP, NS, JM, AI, MC, TO, AO Statistical analysis: Not applicable Obtained funding: Not applicable Overall responsibility: AO Funding None. Disclosures None. Footnotes The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest. Clinical Trial registration ID: CRD420261377751. Appendix (online only) Supplementary Appendix 1 References Associated Data Supplementary Materials Supplementary Appendix 1 Data Availability Statement A protocol for this review was prepared and available via PROSPERO.